Form 4: DocuSign CFO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
DocuSign's Chief Financial Officer, Blake Jeffrey Grayson, sold 6,500 shares of common stock for approximately $462,811 under a pre-arranged 10b5-1 plan.
Summary
- Blake Jeffrey Grayson, Chief Financial Officer of DocuSign, Inc. (DOCU), reported the sale of common stock.
- The transactions occurred on October 1, 2025.
- A total of 1,751 shares were sold at an average price of $70.73 per share, with prices ranging from $70.09 to $70.97.
- An additional 4,749 shares were sold at an average price of $71.38 per share, with prices ranging from $71.09 to $71.82.
- The total number of shares sold was 6,500.
- The total value of the shares sold is approximately $462,811.85.
- These transactions were executed pursuant to a Rule 10b5-1 plan adopted by the reporting person.
- Following these transactions, Blake Jeffrey Grayson beneficially owns 105,660 shares of DocuSign common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While an insider sale could be perceived negatively, the fact that it was executed under a Rule 10b5-1 plan suggests a pre-scheduled, routine transaction rather than a reaction to new, undisclosed information or a change in management's outlook on the company's prospects.
Positives
- The sale was conducted under a pre-arranged Rule 10b5-1 plan, indicating a scheduled transaction rather than a reaction to recent company performance or news.
Negatives
- An insider sale, even if pre-planned, reduces the direct equity stake of a key executive in the company.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This insider transaction report does not provide information directly related to broader industry trends or competitive landscape. It solely details a specific executive's stock transactions.
Stakeholder Impact
- Shareholders: May observe a slight decrease in insider ownership, but the impact is mitigated by the pre-planned nature of the sale under a 10b5-1 plan, which typically reduces concerns about opportunistic selling.
Key Dates
| Date | Description |
|---|---|
| 10/01/2025 | Date of earliest transaction (sale of common stock) |
| 10/02/2025 | Date the Form 4 was signed by the attorney-in-fact |
Recommendation
holdA 'hold' recommendation is appropriate as this Form 4 filing details a routine, pre-scheduled insider stock sale under a 10b5-1 plan. Such transactions are generally not indicative of a significant shift in the company's fundamentals or management's long-term view, and therefore, do not typically warrant a change in investment thesis based solely on this information.
Keywords
DocuSign, DOCU, insider trading, Form 4, stock sale, CFO, Blake Jeffrey Grayson, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.